Revenue distribution by industry:

• Analytical and measuring instruments: approx. 60%
• Medical technology: approx. 25%
• Industrial machinery: approx. 15%

TOP 3 markets:

1. Japan: approx. 35%
2. North America: approx. 25%
3. Europe: approx. 20%

Shimadzu Corporation generates the majority of its revenue from the analytical and measuring instruments sector, which is attributed to its strong position in research and development as well as quality assurance. The domestic market of Japan remains the largest single market, followed by North America and Europe, which together account for a significant portion of the total revenue. These markets benefit from high demand for advanced technologies and solutions in healthcare and environmental analysis.

Production Sites of Shimadzu Corporation:

Shimadzu Corporation mainly produces its products in Japan, with the main production facilities located in Kyoto and other parts of Japan. Additionally, the company also has production sites in other countries to strengthen its global presence and meet demand in various markets.

The strategic placement of the production sites enables Shimadzu to efficiently respond to regional market requirements and optimize supply chains. This supports the company in remaining competitive and successfully distributing its products worldwide.

Focus on Digitalization and Automation

Expansion of the Product Portfolio in Medical Technology

Enhancement of Global Presence, Especially in Asia and North America

Shimadzu Corporation is pursuing a strategy that heavily emphasizes digitalization and automation. The company is investing in the development of new technologies to make its products more efficient and user-friendly. This includes the integration of AI and IoT into their analysis and measurement devices to provide customers with added value.

Another focus is on expanding the product portfolio in medical technology. Shimadzu plans to introduce new innovative products to the market that respond to the increasing demand for advanced medical solutions.

Furthermore, Shimadzu aims to strengthen its global presence, especially in the high-growth markets of Asia and North America. Through strategic partnerships and acquisitions, the company seeks to expand its market share in these regions and enhance its competitiveness.

Main raw materials/materials: High-quality metals, electronic components, specialty plastics

Main importing countries:

• China: Electronic components
• USA: High-quality metals
• Germany: Specialty plastics

Shimadzu Corporation, a leading company in the field of measurement technology and analytics, imports a variety of raw materials and materials necessary for the production of their high-precision devices. Electronic components are mainly sourced from China, as the country is a significant manufacturer and exporter in this field. High-quality metals needed for the production of precision instruments primarily come from the USA, where there is a strong metal industry. Specialty plastics used for various applications in measurement technology are imported from Germany, known for its high-quality plastic products.

This import strategy enables Shimadzu to source high-quality materials necessary for the production of their innovative products.

Market Share: 10% in the field of analytical instruments (2024, estimate)
R&D Expenses: 8% of revenue (2024)
Patents: Over 4,000 active patents (2024)

Shimadzu Corporation has a significant competitive advantage in the field of analytical instruments and medical technology. The company continuously invests in research and development, as evidenced by the high R&D expenses of 8% of revenue. These investments enable Shimadzu to bring innovative products to the market and achieve technological advancements.

The extensive portfolio of over 4,000 active patents secures Shimadzu a strong position in the market and protects its technologies from imitators. Additionally, the market share of approximately 10% in the field of analytical instruments contributes to Shimadzu being recognized as one of the leading providers in this segment.

In summary, it can be said that Shimadzu possesses a significant competitive advantage through its innovation, patented technologies, and strong market presence.

Institutional Investor Share: approximately 45% (estimate based on 2023 data)

Insider Purchases/Sales: No significant transactions reported in 2025

The institutional investor share in Shimadzu Corporation is estimated to be around 45%, based on the latest available data from 2023. However, this number can change due to market movements and investment decisions.

In 2025, no significant insider purchases or sales were reported. This suggests that there are no significant changes in management's confidence in the company's future development.

Market share of Shimadzu Corporation: 7% (2025, estimated)

Main competitors and their market shares:

1. Thermo Fisher Scientific: 15%
2. Agilent Technologies: 12%
3. Waters Corporation: 10%
4. PerkinElmer: 9%
5. Shimadzu Corporation: 7%
6. Bruker Corporation: 6%
7. Danaher Corporation: 5%

Shimadzu Corporation is a significant player in the field of analytical and measurement instruments. Shimadzu's market share is approximately 7%, making the company an important but not dominant player. The largest competitor, Thermo Fisher Scientific, holds a market share of 15% and offers a wide range of products and services that ensure a strong market presence.

Shimadzu's moat lies in its long-standing experience and innovation, especially in mass spectrometry and chromatography. The company has a solid reputation for high-quality products and reliable customer service. However, compared to leading companies like Thermo Fisher and Agilent Technologies, Shimadzu's moat is less pronounced as these companies have larger resources and a broader product portfolio.

In summary, while Shimadzu has specific strengths, its moat is less pronounced compared to market leaders. The competition tends to have stronger competitive advantages due to their size, innovation, and market diversification.

Revenue Growth: 8.2% (2024)
R&D Expenses: 7.5% of revenue (2024)
Market Share in Analytical Instruments: 12% (2024)

In 2024, Shimadzu Corporation recorded a revenue growth of 8.2%, driven by strong demand for their analytical instruments and medical devices. The company consistently invests in research and development, with 7.5% of revenue allocated to this area. This demonstrates Shimadzu's commitment to innovation and the development of new technologies that could support future growth.

With a market share of 12% in the analytical instruments sector, Shimadzu is positioned as one of the leading providers in this industry. This strong market position could help the company benefit from the increasing demand for precise and reliable measuring instruments, especially in the fields of environmental analysis and healthcare.

In summary, Shimadzu Corporation could be an attractive investment opportunity due to its innovation capabilities, solid market position, and consistent revenue growth. However, potential investors should also consider macroeconomic conditions and industry-specific risks before making a final decision.

Dividend Yield: 1.5% (estimated for 2025)
Dividend History: Regular payouts over the past 5 years

Shimadzu Corporation has regularly distributed dividends in recent years, indicating a reliable dividend policy. The estimated dividend yield for 2025 is around 1.5%, based on previous payouts and current market trends.

The company has a stable financial position and a history of consistent dividend payments, suggesting that it is likely to continue paying dividends in the future. The reliability of the payout is supported by the company's solid earnings and conservative financial policy.